LEONARD JOHN M
President and CEO
LEONARD JOHN M has filed 5 SEC Form 4 filings (10 transaction rows) across 2 companies, including NTLA, IQV, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 24, 2026.
On the most recent filing, LEONARD JOHN M is listed as President and CEO at Intellia Therapeutics, Inc. Inside the rolling window, LEONARD JOHN M reported no open-market purchases and 4 open-market sales totaling $1.4M in NTLA. The largest disclosed transaction in the window is a sale of 88,146 NTLA shares on Dec 11, 2025, worth $836K.
Companies traded
Other insiders at NTLA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has LEONARD JOHN M made?
LEONARD JOHN M has filed 5 SEC Form 4 filings (10 transaction rows) across 2 companies, including NTLA, IQV since 2025.
Which companies does LEONARD JOHN M trade?
LEONARD JOHN M has filed SEC Form 4 disclosures for 2 companies, including NTLA, IQV.
When was LEONARD JOHN M's most recent SEC Form 4 filing?
LEONARD JOHN M's most recent SEC Form 4 filing on Tracefour is dated Aug 24, 2026.
What is LEONARD JOHN M's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, LEONARD JOHN M is listed as President and CEO.
What is LEONARD JOHN M's total buy and sell value in the current window?
Inside the rolling retention window, LEONARD JOHN M bought $0 and sold $1.4M based on SEC Form 4 filings.
What was LEONARD JOHN M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 88,146 NTLA shares on 2025-12-11, worth $836K, per SEC Form 4 filings.